ATLASFirst Trust Nasdaq Pharmaceuticals ETF (FTXH): outlook, holdings and fees
First Trust Nasdaq Pharmaceuticals ETF (FTXH) is an exchange-traded fund and is managed by First Trust. The expense ratio is 0.57% and the yield is 0.71%. The ten largest holdings are 55% of the fund.
Fund data as of Oct 14, 2026 · Price Nov 2, 2026
ATLAS view on FTXH
| Last price | $43.96 (-0.6%) |
|---|---|
| ATLAS chance of a higher price in 1 month | 54% |
| Likely 1-month range (50%) | $42.82 – $45.54 |
| Normal 1-day range (±1σ) | ±1.0% |
| Distribution yield | 0.71% |
ATLAS probabilities use the same calibrated model as every stock page. A fair value is shown for companies, not funds; the holdings below link to the fair value of each company.
FTXH fund facts
| Issuer | First Trust |
|---|---|
| Theme | Healthcare |
| Assets under management | $1.1B |
| Expense ratio | 0.57% |
| Number of holdings | 50 |
| Portfolio turnover | 72% |
| Inception | Sep 20, 2016 |
| Exchange | NASDAQ |
The fund will normally invest at least 80% of its net assets (including investment borrowings) in the securities that comprise the index. The index is designed to provide exposure to U.S. companies comprising the pharmaceutical sector that have been selected based upon their liquidity and ranking. It is non-diversified.
FTXH top holdings
| Holding | Sector | Weight |
|---|---|---|
| AbbVie Inc ABBV | Healthcare | 7.80% |
| Eli Lilly and Company LLY | Healthcare | 7.58% |
| Pfizer Inc PFE | Healthcare | 7.16% |
| Merck & Company Inc MRK | Healthcare | 6.91% |
| Johnson & Johnson JNJ | Healthcare | 7.25% |
| Viatris Inc VTRS | Healthcare | 3.95% |
| Biogen Inc BIIB | Healthcare | 3.64% |
| Gilead Sciences Inc GILD | Healthcare | 3.75% |
| Zoetis Inc ZTS | Healthcare | 3.50% |
| Amgen Inc AMGN | Healthcare | 3.58% |
Holdings with an ATLAS page link to their probability range, fair value and earnings calendar.
FTXH sector breakdown
| Sector | Weight |
|---|---|
| Healthcare | 100.0% |
By region: North America 99.5%, United Kingdom 0.5%.
FTXH returns and risk
| Year to date | +24.8% |
|---|---|
| 1 year | +43.9% |
| 3 years (annualised) | +20.0% |
| 5 years (annualised) | +11.6% |
| 10 years (annualised) | +8.9% |
| Volatility (3 years) | 14.1% |
| Sharpe ratio (3 years) | 0.96 |
Past returns do not guarantee future results.
FTXH: frequently asked questions
What does FTXH invest in?
First Trust Nasdaq Pharmaceuticals ETF invests in a portfolio of securities. Its largest holdings are AbbVie Inc (7.8%), Eli Lilly and Company (7.6%), Pfizer Inc (7.2%), Merck & Company Inc (6.9%), Johnson & Johnson (7.2%).
What is the FTXH expense ratio?
0.57% a year: about $57.00 for every $10,000 invested.
What is the FTXH dividend yield?
0.71%. ATLAS does not hold the exact distribution dates for ETFs.
Will FTXH go up?
Nobody can know. The ATLAS model puts the chance of a higher price in one month at 54%, with a likely range (50%) of $42.82 to $45.54 from $43.96 today. It is a probability, not a prediction.
How has FTXH performed?
Year to date +24.8%, one year +43.9%, three years +20.0% a year, five years +11.6% a year. Past returns do not guarantee future results.
Similar ETFs: Healthcare
- State Street Health Care Select Sector SPDR ETF (XLV)
- Vanguard Health Care ETF (VHT)
- iShares Global Healthcare ETF (IXJ)
- iShares U.S. Healthcare ETF (IYH)
- iShares U.S. Medical Devices ETF (IHI)
- Fidelity MSCI Health Care Index ETF (FHLC)
- iShares U.S. Pharmaceuticals ETF (IHE)
- First Trust Health Care AlphaDEX Fund (FXH)
Educational information, not investment advice. Disclaimer